Replies to post #11858 on Cel Sci Corporation (CVM)

[reslabrat]

Delivery of multiple immune stimulating molecules to the tumor microenvironment with reduced systemic toxicity is very exciting. Combined with current standard of care treatments that release tumor associated antigens this therapy will certainly result in increased efficacy!